tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences
X

Need an answer now?

Give us a call

Leave a message, we'll get back to you





Get advice about BPS Bioscience

BPS Bioscience

BPS Bioscience - tebu-bio
The team of antibody experts at tebu-bio offers you an easily accessible, innovative range of primary and secondary research antibody reagents compatible with your protein analysis (western blotting, immunohistochemistry, immunoprecipitation, ELISA, flow cytometry...), cell-based assays and protein expression profiling.

To help you choose your primary and secondary antibodies, get in touch with your local tebu-bio Antibody experts in Belgium, France, Germany, Italy, the Netherlands, the UK, Spain, Portugal and Scandinavia (Denmark, Finland, Norway, Sweden).

Find your BPS Bioscience products below or contact your tebu-bio local office.

Split per category

Antibodies

Primary Antibodies

20 blog articles

2 webpages

20 blog articles


Complete tool box to facilitate Immunotherapy research | tebu-bio's blog Facebook LinkedIn Twitter YouTube

3 novel PD-L1 post-translational modifications identified | tebu-bio's blog Facebook LinkedIn Twitter YouTube

IDO/TDO enzymatic pathway as an additional target for Cancer Drug Discovery | tebu-bio's blog Facebook LinkedIn Twitter YouTube

drug discovery | tebu-bio's blog - Part 3 Facebook LinkedIn Twitter YouTube

New Reporter cell lines for Drug discovery and Immunotherapy checkpoint research | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Cell-based assay to discover new immuno-oncology treatments | tebu-bio's blog Facebook LinkedIn Twitter YouTube

HDACs: Active drug targets for Immunotherapy treatment | tebu-bio's blog Facebook LinkedIn Twitter YouTube

10 Human Immune Checkpoint biomarkers quantified simultaneously | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Proteins with the High Purity (HiPTM) label make the difference | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Versatile method to detect luciferase in reporter cell lines | tebu-bio's blog Facebook LinkedIn Twitter YouTube

PROTACs: A promising strategy in Drug Development | tebu-bio's blog Facebook LinkedIn Twitter YouTube

CAR T-Cell therapy: new hope for Immunotherapy and Cancer treatment | tebu-bio's blog Facebook LinkedIn Twitter YouTube

How to easily screen adenosine A2AR agonists and antagonists? | tebu-bio's blog Facebook LinkedIn Twitter YouTube

IL-17A pathway a key target for immunotherapies | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Measure Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) | tebu-bio's blog Facebook LinkedIn Twitter YouTube

How to improve your reporter gene assays? | tebu-bio's blog Facebook LinkedIn Twitter YouTube

drug discovery | tebu-bio's blog Facebook LinkedIn Twitter YouTube

New Continued use immunotherapy cell line expressing recombinant PD-1 | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Cell-based assay to discover new immuno-oncology treatments | tebu-bio's blog Facebook LinkedIn Twitter YouTube

ADCC | tebu-bio's blog Facebook LinkedIn Twitter YouTube

2 Webpages